Safety and immunogenicity of inactivated COVID-19 vaccine in patients with metabolic syndrome: A cross-sectional observational study

BACKGROUND AND AIMS: The prevalence of metabolic syndrome (MS), wich mainly including hypertension, hyperglycemia, hyperlipidemia, remains high, and the safety and antibody response of inactivated coronavirus disease 2019 (COVID-19) vaccination in patients with metabolic syndrome (MS) is still incon...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Qiao, Yang, Lei, Peng, Ran, Gao, Tao, Chu, Xinglin, Jiang, Depeng, Ke, Dazhi, Ren, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817001/
https://www.ncbi.nlm.nih.gov/pubmed/36620297
http://dx.doi.org/10.3389/fpubh.2022.1067342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817001/
https://www.ncbi.nlm.nih.gov/pubmed/36620297
http://dx.doi.org/10.3389/fpubh.2022.1067342

Ejemplares similares